Back to Business: Pharma Companies Gear Up for Second Half of the Year with KPI Reviews 

As the summer fades, the pharma industry gears up for the critical second half of the year, a time when commercial strategies are sharpened and KPIs are recalibrated. This period is crucial as companies kickstart their 2024 H2 sprints and begin laying the groundwork for their 2025 business objectives. Internal summer conferences have set the stage for this renewed focus, with leaders across the industry aligning on targets and strategies to drive success in the months ahead.  

At BestPractice Nordic, we’ve spent the summer refining our commercial offerings to better serve the pharma industry’s evolving needs. Our focus has been on creating innovative opportunities that enhance the consumer journey, shift perceptions, and challenge industry media standards. We’re excited to share these developments with our partners, offering solutions that not only meet but exceed the industry’s high expectations.  

With a reach that spans over 30,000 users across the Nordic region, BestPractice Nordic is more than just a domestic media partner—we are a gateway to the entire Nordic market. Our platform is designed to support the specific needs of the pharma industry, ensuring that your message reaches the right audience with precision. This fall, we’re proud to participate in key industry events such as Neurologipäivät in Finland this October, as well as the Oncology and Hematology meetings in Bergen and Oslo. These gatherings are pivotal moments for the industry, and we are committed to providing content and commercial solutions that resonate with the attending healthcare professionals (HCPs).  

Our success is defined by the strength of our clinical user database, which is carefully curated to ensure relevance and accuracy. Every user in our network is carefully validated to confirm their status as HCPs, reinforcing the value we provide to our industry partners. As we move into the second half of the year and look ahead to 2025, our commitment remains steadfast: to support the pharma industry with cutting-edge solutions that drive growth and deliver measurable results.  

Book a meeting